Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Sensei Biotherapeutics, Inc. (SNSE) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-170.24M |
|
-- |
|
-- |
|
$170.63M |
|
$-170.63M |
|
$0.39M |
|
$-170.24M |
|
$-170.24M |
|
$-170.24M |
|
$-170.24M |
|
$-170.24M |
|
$-170.24M |
|
$-170.63M |
|
$-170.60M |
|
1.30M |
|
1.30M |
|
$-131.45 |
|
$-131.45 |
|
| Balance Sheet Financials | |
$204.23M |
|
$0.07M |
|
$1.15M |
|
$205.38M |
|
$14.19M |
|
-- |
|
$328.48M |
|
$342.67M |
|
$-137.29M |
|
$-137.29M |
|
$-137.29M |
|
1.34M |
|
| Cash Flow Statement Financials | |
$-10.73M |
|
$-31.44M |
|
$185.83M |
|
$8.67M |
|
$152.32M |
|
$143.66M |
|
$12.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.39 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
124.00% |
|
124.00% |
|
-82.89% |
|
124.00% |
|
$-102.45 |
|
$-8.29 |
|
$-8.29 |
|